Recent Finacing
Recent Raise
Presage Biosciences develops the CIVO intratumoral microdosing platform that injects multiple microdoses into human tumors to simultaneously test drug candidates and combinations in situ for Phase 0 evaluation.
Focus Areas
Recent Investors
Valuation as of 03/02/2021
Total Raised
Funding rounds
Investors
